v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)
Total
Streeterville
Irving
Iliad
Investors
Series L Perpetual Preferred Stock
Streeterville
Series L Perpetual Preferred Stock
Iliad
Series M Perpetual Preferred Stock
Streeterville
Series M Perpetual Preferred Stock
Iliad
Preferred Stock
Series L Perpetual Preferred Stock
Preferred Stock
Series L Perpetual Preferred Stock
Streeterville
Preferred Stock
Series L Perpetual Preferred Stock
Iliad
Preferred Stock
Series M Perpetual Preferred Stock
Preferred Stock
Series M Perpetual Preferred Stock
Streeterville
Preferred Stock
Series M Perpetual Preferred Stock
Iliad
Preferred Stock
Series N Perpetual Preferred Stock
Common Stock
Series N Perpetual Preferred Stock
Common Stock
Common stock - voting
Common Stock
Common stock - voting
Streeterville
Common Stock
Common stock - voting
Irving
Common Stock
Common stock - non-voting
Additional paid-in capital
Additional paid-in capital
Streeterville
Additional paid-in capital
Irving
Additional paid-in capital
Iliad
Additional paid-in capital
Investors
Additional paid-in capital
Series L Perpetual Preferred Stock
Streeterville
Additional paid-in capital
Series L Perpetual Preferred Stock
Iliad
Additional paid-in capital
Series M Perpetual Preferred Stock
Streeterville
Additional paid-in capital
Series M Perpetual Preferred Stock
Iliad
Noncontrolling Interest
Accumulated deficit
Accumulated other comprehensive loss
At The Market Offering
At The Market Offering
Common Stock
Common stock - voting
At The Market Offering
Additional paid-in capital
Restricted Stock Units
Common Stock
Common stock - voting
Pre-Funded Warrants
Common Stock
Common stock - voting
Streeterville
Pre-Funded Warrants
Common Stock
Common stock - voting
Iliad
Beginning Balance at Dec. 31, 2024 $ 6,494,000                                         $ 354,234,000                 $ (791,000) $ (346,482,000) $ (467,000)            
Beginning Balance (in shares) at Dec. 31, 2024                                   15,098     1                                    
Increase (decrease) in Stockholders' Equity (Deficit)                                                                              
Issuance of common stock                                                                   $ 1,756,000   $ 1,756,000      
Issuance of common stock (in shares)                                                                     2,286        
Shares issued in exchange of notes payable and accrued interest   $ 315,000 $ 1,210,000                                       $ 315,000 $ 1,210,000                              
Shares issued in exchange of notes payable and accrued interest (in shares)                                     1,474 400                                      
Warrants issued 1,795,000                                         1,795,000                                  
Deemed dividend to preferred stockholders 0                                                                            
Stock issuance costs, issuance costs attributable to warrants (183,000)                                         183,000                                  
Stock-based compensation 301,000                                         301,000                                  
Net income (loss) (10,596,000)                                                           (132,000) (10,464,000)              
Translation loss (262,000)                                                           (29,000)   (233,000)            
Ending Balance at Mar. 31, 2025 830,000                                         359,428,000                 (952,000) (356,946,000) (700,000)            
Ending Balance (in shares) at Mar. 31, 2025                                   19,258     1                                    
Beginning Balance, Redeemable preferred stock at Dec. 31, 2025                   $ 2,485,000                                                          
Beginning Balance, Redeemable preferred stock (in shares) at Dec. 31, 2025                   121                                                          
Beginning Balance at Dec. 31, 2025 (18,688,000)                                 $ 1,000       380,974,000                 (1,399,000) (399,916,000) (833,000)            
Beginning Balance (in shares) at Dec. 31, 2025                         144     10   199,330     1                                    
Increase (decrease) in Stockholders' Equity (Deficit)                                                                              
Issuance of common stock (in shares)                                                                         69 126,143 45,843
Common shares issued to investors in exchange for Preferred Stock (in shares)                               (10) 595                                            
Warrants issued   1,511,000       $ 2,162,000 $ 479,000   $ 1,910,000   $ 2,485,000                       1,511,000       $ 4,647,000 $ 479,000   $ 1,910,000                  
Warrants issued (in shares)                     (99) (22)   (69) (88)                                                
Warrants issued in exchange for notes payable and accrued interest         $ 179,000                                         $ 179,000                          
Warrants issued in exchange for Royalty Interest   $ 1,590,000   $ 2,222,000                                     $ 1,590,000   $ 2,222,000                            
Preferred stock issued on preferred returns of Series M Preferred Stock (in shares)                           4 9                                                
Stock dividends issued as Series O Convertible Preferred Stock (9,470,000)                                         (9,470,000)                                  
Deemed dividend to preferred stockholders 6,063,000                                                                            
Deemed dividend           $ (2,163,000) $ (479,000) $ (1,511,000) $ (1,910,000)                                   $ (2,163,000) $ (479,000) $ (1,511,000) $ (1,910,000)                  
Stock issuance costs, issuance costs attributable to warrants (4,000)                                         (4,000)                                  
Stock-based compensation 155,000                                         155,000                                  
Net income (loss) 8,723,000                                                           (126,000) 8,849,000              
Translation loss (458,000)                                                           (49,000)   (409,000)            
Ending Balance at Mar. 31, 2026 $ (15,752,000)                                 $ 1,000       $ 378,130,000                 $ (1,574,000) $ (391,067,000) $ (1,242,000)            
Ending Balance (in shares) at Mar. 31, 2026                                   371,980     1